Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.]
| Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.] |
| Pubbl/distr/stampa | London, : BMJ, 2005 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 616.2/0046 |
| Altri autori (Persone) | GibsonPeter, Dr. |
| Collana | Evidence-Based Medicine |
| Soggetto topico |
Respiratory organs - Diseases
Evidence-based medicine |
| ISBN |
1-280-74297-6
9786610742974 0-470-79050-4 0-470-98737-5 1-4051-7237-1 |
| Classificazione | 44.84 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index |
| Record Nr. | UNINA-9910143264803321 |
| London, : BMJ, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.]
| Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.] |
| Pubbl/distr/stampa | London, : BMJ, 2005 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 616.2/0046 |
| Altri autori (Persone) | GibsonPeter, Dr. |
| Collana | Evidence-Based Medicine |
| Soggetto topico |
Respiratory organs - Diseases
Evidence-based medicine |
| ISBN |
1-280-74297-6
9786610742974 0-470-79050-4 0-470-98737-5 1-4051-7237-1 |
| Classificazione | 44.84 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index |
| Record Nr. | UNISA-996211163703316 |
| London, : BMJ, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.]
| Evidence-based respiratory medicine [[electronic resource] /] / edited by Peter Gibson ... [et al.] |
| Pubbl/distr/stampa | London, : BMJ, 2005 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 616.2/0046 |
| Altri autori (Persone) | GibsonPeter, Dr. |
| Collana | Evidence-Based Medicine |
| Soggetto topico |
Respiratory organs - Diseases
Evidence-based medicine |
| ISBN |
1-280-74297-6
9786610742974 0-470-79050-4 0-470-98737-5 1-4051-7237-1 |
| Classificazione | 44.84 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index |
| Record Nr. | UNINA-9910830985803321 |
| London, : BMJ, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evidence-based respiratory medicine / / edited by Peter Gibson ... [et al.]
| Evidence-based respiratory medicine / / edited by Peter Gibson ... [et al.] |
| Pubbl/distr/stampa | London, : BMJ, 2005 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 616.20046 |
| Altri autori (Persone) | GibsonPeter, Dr. |
| Collana | Evidence-Based Medicine |
| Soggetto topico |
Respiratory organs - Diseases
Evidence-based medicine |
| ISBN |
1-280-74297-6
9786610742974 0-470-79050-4 0-470-98737-5 1-4051-7237-1 |
| Classificazione | 44.84 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index |
| Record Nr. | UNINA-9910877793003321 |
| London, : BMJ, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||